ALMS Alumis Inc.
Alumis Inc. (ALMS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $507.0K.
Where they traded
Last open-market purchase: September 8, 2026 , by AKKARAJU SRINIVAS .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS 2 fills | Director | Buy | 546,581 | $10.63 | $5.8M | 4,937,026 | |
| AKKARAJU SRINIVAS 2 fills | Director | Sell | 96,131 | $10.55 | $1.0M | 4,663,735 −2% of holding | |
| AKKARAJU SRINIVAS 2 fills | Director | Buy | 440,140 | $11.17 | $4.9M | 4,711,801 | |
| Schroer John R. | Chief Financial Officer | Sell | 3,282 | $26.37 | $86.5K | 24,718 −11.7% of holding | |
| Hardiman Roy C. | Chief Business & Strategy Ofcr | Sell | 2,692 | $26.37 | $71.0K | 207,746 −1.3% of holding | |
| Goldstein David M | Chief Scientific Officer | Sell | 2,596 | $26.37 | $68.5K | 30,970 −7.7% of holding | |
| Bradley Mark Christopher | Chief Development Officer | Sell | 2,572 | $26.37 | $67.8K | 48,533 −5% of holding | |
| Drappa Jorn | Chief Medical Officer | Sell | 2,447 | $26.37 | $64.5K | 56,892 −4.1% of holding | |
| Pangali Sanam | Chief Legal Officer | Sell | 1,364 | $26.37 | $36.0K | 9,747 −12.3% of holding | |
| Pangali Sanam | Chief Legal Officer | Sell | 5,000 | $28.00 | $140.0K | 11,111 −31% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.